Henning Gruell
- Infectious Diseases top 2%
- Virology top 2%
- Immunology top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Florian KleinKanika VanshyllaPhilipp SchommersClara LehmannFlorian KurthPinkus Tober‐LauLeif Erik SanderChristoph Kreer
- Topics
- SARS-CoV-2 and COVID-19 Research (21 papers)HIV Research and Treatment (20 papers)Immune Cell Function and Interaction (11 papers)
- Partner nations
- GermanyUnited StatesSlovakia
In The Last Decade
Henning Gruell
48 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Infectious Diseases 782
- Virology 377
- Immunology 317
- Molecular Biology 234
- Radiology, Nuclear Medicine and Imaging 185
Countries citing papers authored by Henning Gruell
This map shows the geographic impact of Henning Gruell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Gruell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Gruell more than expected).
Fields of papers citing papers by Henning Gruell
This network shows the impact of papers produced by Henning Gruell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Gruell. The network helps show where Henning Gruell may publish in the future.
Co-authorship network of co-authors of Henning Gruell
This figure shows the co-authorship network connecting the top 25 collaborators of Henning Gruell. A scholar is included among the top collaborators of Henning Gruell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Gruell. Henning Gruell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 15 | |
| 5 | 16 | |
| 6 | 3 | |
| 7 | 10 | |
| 8 | mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantbreakdown → | 243 |
| 9 | 12 | |
| 10 | 6 | |
| 11 | 76 | |
| 12 | 17 | |
| 13 | 9 | |
| 14 | 99 | |
| 15 | 11 | |
| 16 | 13 | |
| 17 | 57 | |
| 18 | 6 | |
| 19 | 8 | |
| 20 | 15 |
About Henning Gruell
Henning Gruell is a scholar working on Virology, Infectious Diseases and Immunology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (21 papers), HIV Research and Treatment (20 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Virology (377 citations), Infectious Diseases (782 citations) and Immunology (317 citations). Henning Gruell has collaborated with scholars based in Germany, United States and Slovakia. Frequent co-authors include Florian Klein, Kanika Vanshylla, Philipp Schommers, Clara Lehmann, Florian Kurth, Pinkus Tober‐Lau, Leif Erik Sander, Christoph Kreer, David Hillus and Michel C. Nussenzweig. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.